Chloé Bazin

About

Chloé Bazin earned her bachelor's degree in Interdisciplinary Natural Sciences (with a focus on organic and computational chemistry) and master's degree in Biology and Computer Science from ETH Zürich. After completing her master's thesis at the Dana-Farber Cancer Institute in Boston, she joined the Netherlands Cancer Institute as a PhD student in March 2025. Working jointly with the Teuwen, Wessels, and Blank groups, Chloé's research focuses on developing AI models to predict patient response and toxicity to neoadjuvant immune checkpoint blockade in melanoma using multimodal data.